We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Therapeutic Hepatitis B Vaccine (Synthesized Peptide εPA-44) Joint Entecavir in Treating Chronic Hepatitis B Patients (THBVJEITCHBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01326546
Recruitment Status : Unknown
Verified June 2012 by Chongqing Jiachen Biotechnology Ltd..
Recruitment status was:  Active, not recruiting
First Posted : March 31, 2011
Last Update Posted : June 13, 2012
Third Military Medical University
Information provided by (Responsible Party):
Chongqing Jiachen Biotechnology Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2012
  Estimated Study Completion Date : March 2013